Reuter James Wealth Management, LLC Biogen Inc. Transaction History
Reuter James Wealth Management, LLC
- $134 Million
- Q2 2024
A detailed history of Reuter James Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 929 shares of BIIB stock, worth $171,660. This represents 0.16% of its overall portfolio holdings.
Number of Shares
929
Previous 1,035
10.24%
Holding current value
$171,660
Previous $223,000
3.59%
% of portfolio
0.16%
Previous 0.16%
Shares
11 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.07 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.02 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.69 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.31 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.05 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $26.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...